These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 20175707)

  • 1. Post hoc magnetic resonance imaging cannot justify the conclusions of WHIMS.
    Naftolin F; King J; Morrison JH
    Gynecol Endocrinol; 2010 Jun; 26(6):391-2. PubMed ID: 20175707
    [No Abstract]   [Full Text] [Related]  

  • 2. Estrogen and dementia: insights from the Women's Health Initiative Memory Study.
    Schneider LS
    JAMA; 2004 Jun; 291(24):3005-7. PubMed ID: 15213214
    [No Abstract]   [Full Text] [Related]  

  • 3. IMS updates its recommendations on the use of HRT.
    Brown S
    Menopause Int; 2013 Sep; 19(3):105-6. PubMed ID: 24195130
    [No Abstract]   [Full Text] [Related]  

  • 4. Estrogen-progestin combinations for postmenopausal use.
    Med Lett Drugs Ther; 1995 Jun; 37(950):53-4. PubMed ID: 7760770
    [No Abstract]   [Full Text] [Related]  

  • 5. Does estrogen/progestin therapy in post-menopausal women decrease their risk of fracture?
    Groh KW; Stevermer JJ
    J Fam Pract; 2001 Nov; 50(11):926. PubMed ID: 11711004
    [No Abstract]   [Full Text] [Related]  

  • 6. Consortium for the Assessment of Research on Progestins and Estrogens (CARPE) Fort Worth, Texas August 1-3, 2003.
    Simpkins JW; Singh M
    J Womens Health (Larchmt); 2004 Dec; 13(10):1165-8. PubMed ID: 15650349
    [No Abstract]   [Full Text] [Related]  

  • 7. Estrogen replacement therapy may reduce panic symptoms.
    Chung CK; Remington ND; Suh BY
    J Clin Psychiatry; 1995 Nov; 56(11):533. PubMed ID: 7592508
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of estrogen plus progestin on risk of dementia.
    Brinton RD; Nilsen J
    JAMA; 2003 Oct; 290(13):1706; author reply 1707-8. PubMed ID: 14519699
    [No Abstract]   [Full Text] [Related]  

  • 9. Hormone replacement therapy.
    Med Lett Drugs Ther; 2002 Sep; 44(1138):78. PubMed ID: 12238487
    [No Abstract]   [Full Text] [Related]  

  • 10. Estrogen research. Brain researchers try to salvage estrogen treatments.
    Wickelgren I
    Science; 2003 Nov; 302(5648):1138-9. PubMed ID: 14615509
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of low-dose continuous combined conjugated estrogens and medroxyprogesterone acetate on menopausal symptoms, body weight, bone density, and metabolism in postmenopausal women.
    Gambacciani M; Ciaponi M; Cappagli B; Genazzani AR
    Am J Obstet Gynecol; 2001 Nov; 185(5):1180-5. PubMed ID: 11717654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination hormone replacement therapy and dementia.
    Wooltorton E
    CMAJ; 2003 Jul; 169(2):133. PubMed ID: 12874164
    [No Abstract]   [Full Text] [Related]  

  • 13. Inflammation, coronary artery disease, and hormones.
    Lobo RA
    Menopause; 2008; 15(6):1036-8. PubMed ID: 18779754
    [No Abstract]   [Full Text] [Related]  

  • 14. Incidence of breast cancer in a 22-year study of women receiving estrogen-progestin replacement therapy.
    Nachtigall MJ; Smilen SW; Nachtigall RD; Nachtigall RH; Nachtigall LE
    Obstet Gynecol; 1992 Nov; 80(5):827-30. PubMed ID: 1328978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of estrogen replacement therapy on platelet aggregation and adenosine triphosphate release in postmenopausal women.
    Bar J; Tepper R; Fuchs J; Pardo Y; Goldberger S; Ovadia J
    Obstet Gynecol; 1993 Feb; 81(2):261-4. PubMed ID: 8380912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential prevalence of quality-of-life categories (domains) in Asian women and changes after therapy with three doses of conjugated estrogens/medroxyprogesterone acetate: the Pan-Asia Menopause (PAM) study.
    Limpaphayom KK; Darmasetiawan MS; Hussain RI; Burriss SW; Holinka CF; Ausmanas MK
    Climacteric; 2006 Jun; 9(3):204-14. PubMed ID: 16766434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The time has come to stop letting the HERS tale wag the dogma.
    Mendelsohn ME; Karas RH
    Circulation; 2001 Nov; 104(19):2256-9. PubMed ID: 11696459
    [No Abstract]   [Full Text] [Related]  

  • 18. Estrogen plus progestin and the risk of peripheral arterial disease: the Women's Health Initiative.
    Hsia J; Criqui MH; Rodabough RJ; Langer RD; Resnick HE; Phillips LS; Allison M; Bonds DE; Masaki K; Caralis P; Kotchen JM;
    Circulation; 2004 Feb; 109(5):620-6. PubMed ID: 14769684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative and qualitative changes in lipids, lipoproteins, apolipoprotein A-I, and sex hormone-binding globulin due to two doses of conjugated equine estrogen with and without a progestin.
    Miller VT; Muesing RA; LaRosa JC; Stoy DB; Fowler SE; Stillman RJ
    Obstet Gynecol; 1994 Feb; 83(2):173-9. PubMed ID: 8290177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of conjugated estrogen and Org OD14 on serum lipoprotein and apolipoprotein in perimenopausal and postmenopausal women].
    Bai W; Yang X; Zheng S
    Zhonghua Fu Chan Ke Za Zhi; 1999 May; 34(5):293-6. PubMed ID: 11326938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.